Evidence map›Paper›PMID 25203216›Full record

ArticleACS chemical biology2014

A distinct MaoC-like enoyl-CoA hydratase architecture mediates cholesterol catabolism in Mycobacterium tuberculosis.

Meng Yang, Kip E Guja, Suzanne T Thomas, Miguel Garcia-Diaz, Nicole S Sampson

Abstract read
In one paragraph

Article in ACS chemical biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Crystal Structure of Mesaconyl-CoA Hydratase fromJournal of microbiology and biotechnology · 2023
    Article
  13. Targeted Mutagenesis of Mycobacterium Strains by Homologous Recombination.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Comparative Analysis of Bile-Salt Degradation inApplied and environmental microbiology · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Meng YangDepartment of Chemistry, Stony Brook University , Stony Brook, New York 11794-3400, United States.
Kip E Guja
Suzanne T Thomas
Miguel Garcia-Diaz
Nicole S Sampson
Stony Brook University · US

Funding

Life Science and Biomedical technology Research center at NSLS-II LSBRP41GM111244 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MCSWEENEY, SEAN · 2014 to 2018
$16.4M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008444 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI FROHMAN, MICHAEL A. · 1992 to 2024
$12.6M
CHOLESTEROL OXIDASE LOOP RESIDUES &CATALYSISR01HL053306 · NHLBI · STATE UNIVERSITY NEW YORK STONY BROOK · PI SAMPSON, NICOLE S · 2001 to 2009
$2.6M
SBU Chemistry-Biology Interface Training ProgramT32GM092714 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI SAMPSON, NICOLE S, TONGE, PETER J · 2010 to 2019
$1.7M
Mechanisms of mitochondrial transcriptionR01GM100021 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI GARCIA-DIAZ, MIGUEL · 2012 to 2016
$1.5M
Steroid Hormone Biosynthesis by M.tbR21AI092455 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI SAMPSON, NICOLE S · 2011 to 2012
$425k
Investigation of Mycobacterial GMC Oxidoreductase Rv3409cR21AI085349 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI SAMPSON, NICOLE S · 2010 to 2011
$422k
MALDI-TOF SPECTROM: PROTEIN: INHIBIT FATTY ACID BIOSYNTHESIS IN M TUBERCULOSISS10RR021008 · NCRR · STATE UNIVERSITY NEW YORK STONY BROOK · PI SAMPSON, NICOLE S. · 2005 to 2005
$270k
CHOLESTEROL OXIDASE LOOP RESIDUES AND CATALYSISR29HL053306 · NHLBI · STATE UNIVERSITY NEW YORK STONY BROOK · PI SAMPSON, NICOLE S. · 1995 to 2000
$110k
Characterization of an essential mitochondrial rRNA methyltransferaseF30ES022930 · NIEHS · STATE UNIVERSITY NEW YORK STONY BROOK · PI GUJA, KIP E · 2013 to 2014
$95k
NCI NIH HHS Y1-CO-1020NCRR NIH HHS RR021008NCRR NIH HHS S10 RR021008NHLBI NIH HHS HL53306NHLBI NIH HHS R01 HL053306NHLBI NIH HHS R29 HL053306NIAID NIH HHS AI065251NIAID NIH HHS AI085349NIAID NIH HHS AI092455NIAID NIH HHS R21 AI085349NIAID NIH HHS R21 AI092455NIEHS NIH HHS F30 ES022930NIEHS NIH HHS F30-ES022930NIGMS NIH HHS P41 GM111244NIGMS NIH HHS R01 GM100021NIGMS NIH HHS R01-GM100021NIGMS NIH HHS T32 GM008444NIGMS NIH HHS T32 GM092714NIGMS NIH HHS Y1-GM-1104
6 · The paper itself

Abstract

The Mycobacterium tuberculosis (Mtb) igr operon plays an essential role in Mtb cholesterol metabolism, which is critical for pathogenesis during the latent stage of Mtb infection. Here we report the first structure of a heterotetrameric MaoC-like enoyl-CoA hydratase, ChsH1-ChsH2, which is encoded by two adjacent genes from the igr operon. We demonstrate that ChsH1-ChsH2 catalyzes the hydration of a steroid enoyl-CoA, 3-oxo-4,17-pregnadiene-20-carboxyl-CoA, in the modified β-oxidation pathway for cholesterol side chain degradation. The ligand-bound and apoenzyme structures of ChsH1-ChsH2(N) reveal an unusual, modified hot-dog fold with a severely truncated central α-helix that creates an expanded binding site to accommodate the bulkier steroid ring system. The structures show quaternary structure shifts that accommodate the four rings of the steroid substrate and offer an explanation for why the unusual heterotetrameric assembly is utilized for hydration of this steroid. The unique αβ heterodimer architecture utilized by ChsH1-ChsH2 to bind its distinctive substrate highlights an opportunity for the development of new antimycobacterial drugs that target a pathway specific to Mtb.

Indexed as

CholesterolEnoyl-CoA HydrataseMycobacterium tuberculosisCholesterolEnoyl-CoA Hydratase

Identifiers

PMID25203216
PMCPMC4245171
OpenAlexW2064234052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.